TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
GOSS

Gossamer Bio Inc

Healthcare · Biotechnology

10.90$ +0.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

Gossamer Bio Inc (GOSS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -171 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow GOSS
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.0 -5.7 -51 -145 -176 -189 -187 -159 -3.5 -171
0.0 0.3 0.3 3.1 4.3 5.2 4.4 4.4 4.2 1.0
– 0.0 31 21 39 32 43 29 21 11
0.0 0.0 81 21 38 32 43 – – –
0.1 1.0 15 10 -3.1 0.8 -4.5 -15 39 -14
3.5 3.5 21 6.6 25 1.6 0.5 0.0 0.0 0.1
-145 -145 -145 -147 215 -117 -1.0 -111 29 156
– – 303 293 118 3.3 123 0.4 0.6 –
0.0 6.0 0.0 28 194 -5.8 -5.8 -12 -13 0.0
0.0 6.0 301 322 313 3.3 117 190 -11 6.4
0.0 0.3 105 30 352 -303 -71 -80 14 -8.3
0.0 -5.7 -72 -151 -201 -191 -188 -159 -3.5 -171

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?